Ligand validation:2QE0

NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE

NAP is a Ligand Of Interest in 2QE0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2QE0_NAP_C_3476	47%	7%	0.175	0.915	2.24	2.5	14	26	6	0	100%	0.71
2QE0_NAP_A_1476	39%	17%	0.192	0.9	1.77	1.83	9	12	8	0	100%	0.71
2QE0_NAP_D_4476	32%	16%	0.198	0.874	1.64	2.01	10	12	9	0	100%	0.74
2QE0_NAP_B_2476	28%	16%	0.203	0.853	1.7	1.95	11	13	7	0	100%	0.67
2ID2_NAP_C_3003	73%	17%	0.13	0.956	2.07	1.52	12	10	4	0	100%	0.8
2ESD_NAP_C_3476	23%	17%	0.263	0.886	2.06	1.54	11	12	0	0	100%	0.5
2X9G_NAP_B_1269	100%	46%	0.031	0.997	0.96	1.14	1	5	0	0	100%	1
2J8T_NAP_A_1316	100%	49%	0.033	0.996	0.97	1.01	3	2	1	0	100%	1
3LQL_NAP_A_500	100%	43%	0.035	0.996	1.13	1.07	3	4	1	0	100%	1
3LD5_NAP_A_500	100%	31%	0.033	0.993	1.34	1.4	7	6	2	0	100%	1
3M4H_NAP_A_500	100%	44%	0.037	0.997	1.12	1.04	5	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.